Exchange: NYSEMkt·Updated 07:39 PM EDT
PLX logo

PLX Protalix BioTherapeutics Inc.

$2.46
$0.08
(3.33%)
Today
Closed $2.48
$0.02
(0.81%)
After Hours
Reported EarningsAug 12
Mkt Cap$193.37M
Vol1.02M

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
33

Bearish Sentiment

How do you feel about PLX?

Advertisement|Remove ads.